APLLTDNSEAlembic Pharmaceuticals Limited· PharmaceuticalsMediumNeutral
Announced Wed, 1 Apr · 14:11 IST

Alembic Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Rajkumar Baheti as Non- Executive Non Independent Director of the company w.e.f. April 01, 2026.

Management Changes View source PDF

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹665.00
prior close
₹675.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.0+0.2+0.1-1.3-1.2+4.2+10.4+8.3+7.7+13.2+15.3+8.9+24.8
Up moveDown movePending
AI summary

Alembic Pharmaceuticals has confirmed the appointment of Mr. Rajkumar Baheti (DIN: 00332079) as a Non-Executive Non-Independent Director, effective April 1, 2026. The appointment was approved by the Board on the recommendation of the Nomination and Remuneration Committee and subsequently cleared by shareholders through a Postal Ballot on March 31, 2026. Mr. Baheti is a Commerce graduate and a Fellow Chartered Accountant as well as a Fellow Company Secretary with 44 years of experience in finance, corporate finance, financial governance, and regulatory compliance. The company has confirmed he is not debarred by SEBI and is not related to any existing Directors or Key Managerial Personnel.

Likely market impact

This is a routine governance update with no material impact on shareholders. Adding a senior finance veteran to the board may strengthen financial oversight, but the appointment does not change the company's operations or outlook.